Aqeela Imamdin
Cape Heart Institute, University Of Cape Town
Cape Town, WC, South Africa
Cape Town, WC, South Africa
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Effects of Intralipid on myocardial dysfunction and SAFE pathway signaling following ex vivo global ischemia-reperfusion.
Journal: Experimental and molecular pathology
Published: November 04, 2025
Cardioprotection with Intralipid During Coronary Artery Bypass Grafting Surgery on Cardiopulmonary Bypass: A Randomized Clinical Trial.
Journal: Cardiovascular drugs and therapy
Published: May 30, 2024
Doxorubicin-induced cardiotoxicity and risk factors.
Journal: International journal of cardiology. Heart & vasculature
Published: July 24, 2023
Effect of Remote Ischaemic Conditioning on the Inflammatory Cytokine Cascade of COVID-19 (RIC in COVID-19): a Randomized Controlled Trial.
Journal: Cardiovascular drugs and therapy
Published: November 20, 2022
Exploring the Role of Serotonin as an Immune Modulatory Component in Cardiovascular Diseases.
Journal: International journal of molecular sciences
Published: November 08, 2022
Correction to: RIC in COVID-19-a Clinical Trial to Investigate Whether Remote Ischemic Conditioning (RIC) Can Prevent Deterioration to Critical Care in Patients with COVID-19.
Journal: Cardiovascular drugs and therapy
Published: July 07, 2021
RIC in COVID-19-a Clinical Trial to Investigate Whether Remote Ischemic Conditioning (RIC) Can Prevent Deterioration to Critical Care in Patients with COVID-19.
Journal: Cardiovascular drugs and therapy
Published: June 16, 2021
Sphingosine-1-phosphate (S1P) activates STAT3 to protect against de novo acute heart failure (AHF).
Journal: Life sciences
Published: October 30, 2017
Cardiac preconditioning with sphingosine-1-phosphate requires activation of signal transducer and activator of transcription-3.
Journal: Cardiovascular journal of Africa
Published: December 09, 2013
Showing 1-9 of 9
Last Updated: 09/26/2026